The effect of lonidamine (LND) on radiation and thermal responses of human and rodent cell lines.
Rodent and human cells were tested for response to Lonidamine (LND) (1-(2,4 dichlorobenzyl) 1-indazol-3-carboxylic acid) combined with radiation or hyperthermia. Lonidamine exposure before, during, and after irradiation caused varying degrees of inhibition of potentially lethal damage (PLD) repair which was cell line dependent. In human glioma, melanoma, squamous cell carcinoma, and fibroblasts, LND exposure did not inhibit or only partially inhibited repair of potentially lethal damage. LND up to 100 micrograms/ml produced only a low level of toxicity in these cells and only slightly inhibited glucose consumption at the maximum concentration. In human glioma cells, LND treatment alone did not inhibit PLD repair, but when combined with hyperthermia treatment at moderate levels easily achievable in the clinic, there was complete inhibition of potentially lethal damage repair. These data suggest that LND effectiveness is cell type dependent. Combinations of LND, hyperthermia, and radiation may be effective in cancer therapy especially in tumors such as glioma in which repair of potentially lethal damage may be extensive.
Raaphorst
G P
GP
Medical Physics Department, Ottawa Regional Cancer Centre, Ontario, Canada.
Feeley
M M
MM
Danjoux
C E
CE
Martin
L
L
Fisher
B
B
Maroun
J
J
DeSanctis
A J
AJ
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002294:Carcinoma, Squamous Cell / Q000503:physiopathology / Q000628:therapy; D002461:Cell Line, Transformed / Q000187:drug effects / Q000528:radiation effects; D002470:Cell Survival; D006224:Cricetinae; D005347:Fibroblasts / Q000187:drug effects / Q000528:radiation effects; D005910:Glioma / Q000503:physiopathology / Q000628:therapy; D006801:Humans; D006979:Hyperthermia, Induced; D007191:Indazoles / Q000494:pharmacology*; D008545:Melanoma / Q000503:physiopathology / Q000628:therapy; D051379:Mice; D009369:Neoplasms / Q000503:physiopathology / Q000628:therapy*; D011878:Radiotherapy; D014407:Tumor Cells, Cultured / Q000187:drug effects / Q000528:radiation effects
D000970:Antineoplastic Agents; D007191:Indazoles; C016371:lonidamine